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A repetitive-extragenic palindromic PCR (rep-PCR) subtyping method (DiversiLab) in conjunction
with ribotyping, toxinotyping and antimicrobial-susceptibility testing was used to detect subtypes
within Clostridium difficile ribotypes 027 and 078. Clinical isolates of ribotypes 027 (toxinotype
III) (n530) and 078 (toxinotype V) (n523) were provided by health-care facilities across the
Republic of Ireland over 2 months in 2006 and 1 month in 2009. Ribotype 027 isolates were
significantly more related to each other (9 different subtype profiles) when compared to ribotype
078 isolates (14 different profiles) (P50.001; cut-off .90% similarity). Almost half of ribotype
078 isolates (45.5%) showed no relationship to each other. The clonality of ribotype 027 isolates
suggests effective adaptation to the human niche, whereas the considerable genetic diversity
within ribotype 078 isolates suggests that they may have originated from a variety of sources.
Subtyping correlated well with antimicrobial susceptibility, in particular clindamycin susceptibility
for ribotype 027, but diverse antimicrobial-susceptibility profiles were seen in ribotype 078
isolates, even within a single health-care facility. Between 2006 and 2009, a change in the
predominant subtype of ribotype 027 was seen, with the recent clone representing half of all
ribotype 027 isolates studied. This strain exhibited 89% similarity to a rep-PCR profile of the
North American NAP-1 strain.
INTRODUCTION
Clostridium difficile infection (CDI) is recognized as a
major cause of health-care-acquired antibiotic-associated
diarrhoea and pseudomembranous colitis. Several molecu-
lar typing methods have been employed to study C.
difficile, e.g. PCR ribotyping, PFGE, multilocus variable
number tandem repeat analysis (MLVA) and repetitive-
extragenic palindromic PCR (rep-PCR), each with various
advantages and disadvantages (Killgore et al., 2008; Kuijper
et al., 2009). rep-PCR profiling relies on variations in the
copy number and location of repetitive elements dispersed
throughout the genome. PCR amplification between these
elements results in DNA amplicons of various sizes and
frequencies giving rise to individual rep-PCR profiles.
Discrimination of subtypes within ribotypes by rep-PCR
(Northey et al., 2005; Rahmati et al., 2005; Spigaglia &
Mastrantonio, 2003), randomly amplified polymorphic
DNA techniques (Fawley et al., 2003) and a commercially
available semi-automated rep-PCR system (DiversiLab,
Bacterial Barcodes; bioMe´rieux) has been useful for further
studying C. difficile epidemiology and these methods have
shown good reproducibility for this organism (Healy et al.,
2005; Pasanen et al., 2011; Spigaglia & Mastrantonio, 2003).
Reports of CDI have been increasingly associated with a
hypervirulent strain, PCR ribotype 027 [PFGE type NAP-1
(North American pulsotype-1)] (Kuijper et al., 2006, 2007;
McDonald et al., 2005). Studies of ribotype 027/NAP-1
epidemiology using different molecular subtyping methods
Abbreviations: CDI, Clostridium difficile infection; HPSC–HSE, Health
Protection Surveillance Centre and Health Service Executive; MLSB,
macrolide–lincosamide–streptogramin B; MLVA, multilocus variable
number tandem repeat analysis; rep-PCR, repetitive-extragenic pal-
indromic PCR.
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have identified some clonal strains (Killgore et al., 2008),
whereas others have distinguished hospital-related clusters
(Fawley et al., 2008). The spread of ribotype 027/NAP-1
mainly correlates with resistance to fluoroquinolones,
although outbreaks caused by less common clindamycin-
resistant strains have occurred (Johnson et al., 1999;
Kuijper et al., 2008), with the first European cases reported
in Ireland (Drudy et al., 2008). MLVA of these isolates
differentiated distinct clindamycin-resistant and -suscep-
tible clusters, despite the geographical proximity of the
sources (Drudy et al., 2008).
A recently emerging PCR ribotype, 078 (PFGE type NAP-7
or -8), has been identified in food and environmental
sources, and is associated with community-acquired
infections (Jhung et al., 2008; Keel et al., 2007).
Prevalence of this strain is increasing in Europe (Brazier
et al., 2008; Debast et al., 2009; Goorhuis et al., 2008a, b;
Keel et al., 2007; Rupnik et al., 2008). The increase in the
prevalence of ribotype 078 appears to have mirrored a
reduction in the prevalence of ribotype 027 in The
Netherlands (Hensgens et al., 2009). In a recent national
study in Ireland, ribotype 078 accounted for 9.4% of
isolates, whereas ribotype 027 accounted for 18.7%
(n5107) (Burns et al., 2010b). Antimicrobial-susceptibility
patterns of ribotype 078 isolates are less well documented.
In a recent study in The Netherlands it was reported that
isolates cultured from pigs exhibited identical susceptibility
patterns and a genetic relationship to human isolates
suggesting possible animal-to-human transmission (zoo-
nosis) (Debast et al., 2009). Human-to-human transmis-
sion of ribotype 078 strains is less well characterized,
although it has been suggested during a recent outbreak of
CDI due to ribotype 078 in the Republic of Ireland (Burns
et al., 2010a).
The distinctive differences in genetic diversity, infection
origin and antimicrobial susceptibility between C. difficile
ribotypes 027 and 078 highlight the importance of an
epidemiological study of circulating ribotype 027 and 078
strains. One approach, stratifying antimicrobial-suscepti-
bility profiles with enhanced genotyping, may identify
subtypes specific to health-care settings, facilitate monitor-
ing of their potential for spread and track the emergence of
multi-resistant, increasingly virulent strains of ribotype 078
in the human population.
METHODS
Bacterial isolates and patient clinical history. A total of 53 well-
characterized isolates of C. difficile ribotypes 027 (n530) and 078
(n523) were selected from isolates previously collected from patients
with CDI in 14 hospitals across the Republic of Ireland (Fig. 1) during
2 months in 2006 (n510) and 1 month in 2009 (n543). Ribotypes
027 and 078 comprised 37.7 and 1.9%, respectively, of all C. difficile
strains isolated in 2006, and 18.7 and 9.4%, respectively, of all 2009
isolates (Burns et al., 2010b). Clinical details were collected from
patients, including origin of infection as defined by Kuijper et al.
(2006).
Antimicrobial-susceptibility testing. Antimicrobial susceptibility
to MLSB (macrolide–lincosamide–streptogramin B) antibiotics (clin-
damycin and erythromycin), fluoroquinolones (ciprofloxacin, levo-
floxacin and moxifloxacin), metronidazole and vancomycin were
determined by the Etest method (bioMe´rieux). Isolates of standard-
ized McFarland inoculum were streaked onto pre-reduced Brucella
agar plates supplemented with vitamin K1, haemin and 5% (v/v)
sheep blood (BD Biosciences). Etest strips were laid directly on the
agar surface and incubated at 37 uC for 48 h. The MIC (mg ml21) for
all antibiotics was measured at the ellipse of inhibited growth.
Breakpoints of susceptibility for moxifloxacin, clindamycin and
erythromycin were defined by reference to the Clinical and
Laboratory Standards Institute (CLSI, 2007) and those for cipro-
floxacin and levofloxacin were defined by reference to the European
Committee on Antimicrobial Susceptibility Testing (www.eucast.org
– 2010, v. 2.6).
DNA purification. Genomic DNA was purified from bacterial pellets
following overnight anaerobic growth in Schaedler anaerobe broth
(Oxoid) at 37 uC. After enzymic lysis of cell walls, DNA was extracted
using the Wizard genomic DNA purification kit (Promega) and
assessed for concentration and purity with a NanoDrop spectropho-
tometer (Thermo Scientific) before use in PCR.
PCR ribotyping. Isolates were characterized as ribotype 027 or 078
by 16–23S intergenic-spacer PCR performed using the method
outlined by Stubbs et al. (1999). Gel electrophoresis fingerprints
were analysed using BioNumerics software (version 6.01; Applied
Maths) and ribotypes were assigned by comparison to reference
strains from the Leiden University Medical Centre library, Leiden,
The Netherlands.
Toxinotyping. Isolates were toxinotyped as described by Rupnik et al.
(1998). DNA amplicons generated by PCR of the first 3 kb of the
toxin B gene (B1) and 3 kb of the C-terminal region of the toxin A
gene (A3) were digested by restriction enzymes HincII, AccI and EcoRI
producing characteristic banding patterns.
rep-PCR DNA fingerprinting. Genomic DNA was amplified using
the DiversiLab Clostridium kit (Bacterial Barcodes; bioMe´rieux)
Fig. 1. A schematic map of the Republic of Ireland indicating
health-care facilities included in this study. Clinical C. difficile
isolates in this study were collected from health-care facilities from
a variety of geographical locations. The facilities have been coded
(A–M) and are separated into their geographical regions for
illustration of proximity.
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according to the manufacturer’s instructions and as described by
Pasanen et al. (2011). Positive and negative controls (supplied in the
kit) were included and assessed in parallel to validate the reaction.
DNA amplicons were separated on microfluidics chips (DNA
LabChip device; Caliper Technologies) using a 2100 Bioanalyser
(Agilent Technologies) (Healy et al., 2005). DNA standard markers
were used to normalize sample runs and a molecular ladder (200–
4000 bp marker provided with kit) was included. Data interpretation
and analysis were carried out within the DiversiLab software (version
3.4) utilizing dendrograms, similarity matrices and virtual gel images
generated from fluorescence intensity graphs after normalization.
Percentage similarities between virtual gels generated from isolates
were calculated using the Kullback–Liebler band-based method,
weighted on the presence or absence of bands.
The basis for discrimination between strains was defined by the
DiversiLab strain typing analysis guide (provided online with the
software) parameters as follows: similarity greater than 97% was
defined as indistinguishable; similarity greater than 95% was defined
as similar; similarity less than 95% was considered different but
related; and similarity less than 90% was considered unrelated.
Subtypes were assigned where two or more isolates exhibited greater
than 90% similarity to each other. Statistical significance was
calculated using x2 and Fisher’s exact tests.
RESULTS AND DISCUSSION
Characterization of isolates
Isolates were characterized by PCR ribotyping as either
ribotype 027 or 078. Toxinotyping confirmed that all
isolates of ribotype 078 were toxinotype V. Ribotype 027
isolates were confirmed as toxinotype III.
All isolates were found to be susceptible to both metroni-
dazole and vancomycin (MIC ranges of 0.25–1.5 and
0.0064–0.38 mg ml21, respectively) and resistant to cipro-
floxacin (MIC range 8 to .32 mg ml21). Antimicrobial-
resistance profiles were assigned to isolates based on patterns
of susceptibility in response to fluoroquinolones, moxiflox-
acin, levofloxacin and the MLSB antibiotics (erythromycin
and clindamycin). Susceptibility profiles ranged from
resistance to all fluoroquinolone and MLSB antimicrobials
(denoted as profile 1) to susceptibility to erythromycin only
(denoted as profile 9).
Diversity of isolates as defined by rep-PCR
subtyping
rep-PCR fingerprints for isolates characterized as ribotypes
027 and 078 were generated, and subsequent dendrograms
were created and analysed. At a cut-off point of .90%
similarity, four main subtypes within ribotype 027 could be
identified (Fig. 2), one of which (denoted subtype 1)
contained half of all ribotype 027 isolates analysed. Isolates
within this subtype originated from health-care facilities in
all geographically distinct regions, thus confirming clonal
spread within our study population and that this subtype
may therefore exhibit a competitive genetic fitness over
others in the current health-care environment nationwide.
A comparison between the virtual gel fingerprint profiles of
study isolates and those in a commercially provided
‘DiversiLab C. difficile library’ confirmed that isolates of
rep-PCR subtype 1 were 89% similar to a North American
pulsotype-1 (NAP-1) isolate (McDonald et al., 2005) (data
not shown). Similarities between European ribotype 027
isolates and North American strains have been shown by
PFGE (Fawley et al., 2008; Smith, 2005). The predominant
subclone of ribotype 027 in Ireland is related to the
hypervirulent NAP-1 epidemic strain; however, other
subtypes exist that are unrelated.
The remaining ribotype 027 isolates clustered within three
different rep-PCR subtypes unrelated to the predominant
clone. These lesser subtypes may not have been able to
dominate due to certain characteristics, such as a slower
growth rate, reduced sporulation/environmental persis-
tence or reduced toxin production/virulence, and were
either from the same hospital (subtype 4) or neighbouring
regions (subtype 3) suggesting a reduced ability to spread.
Five isolates (16%) were unrelated to either of these
subtypes or to each other (,90% similarity).
Heterogeneity within ribotype 027 has been reported by
others in European isolates (Fawley et al., 2008) and we
postulate that ribotype 027 isolates may not have equal
virulence potential, and the emphasis on diagnostic
laboratories to identify isolates as markers of potential
outbreaks by ribotyping alone may be of limited use.
Ribotype 027 isolates were significantly more likely to be
related to each other (similarity ¢95%) than ribotype 078
isolates (P50.001), which exhibited greater genetic diversity;
63 % of ribotype 027 isolates were considered to be
indistinguishable from at least one other (.97% similarity),
compared to only 17% of ribotype 078 isolates. At a cut-off
point of.90% similarity, five main subtypes within ribotype
078 could be identified (Fig. 3), but 45.5% of ribotype 078
isolates were considered to be unrelated to each other.
The closest related ribotype 078 isolates originated from
either the same health-care source (hospitals G and E) or
health-care sources within the same region (hospitals G and
D). Isolates with a community-associated origin and from
nursing homes were closely related to isolates from health-
care facilities in the locality, suggesting common sources of
infection. Related isolates in subtype 2, however, originated
from geographically distinct facilities (.400 km away).
Subtype diversity was seen between isolates from health-care
facilities of close geographical proximity (within a 15 km
radius; hospitals G, A and L). Variation between human
ribotype 078/toxinotype V isolates has also been confirmed
by PFGE analysis (SmaI digestion) with isolates grouped into
approximately seven distinct clusters of ,90% similarity
including PFGE types NAP-7 and NAP-8 (Jhung et al., 2008).
Other studies using rep-PCR as well as other typing
methods have identified that ribotype 078/toxinotype V
isolates show a degree of relatedness, in contradiction to
the findings presented here (Lin et al., 2011; Pasanen et al.,
2011). However, these studies involved either a small
K. Solomon and others
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number of ribotype 078 isolates or were not supported
directly by alternative typing methods. Bakker et al. (2010)
determined that out of three ribotype 078 isolates from
Ireland, two were identical and one was genetically unrelated
based on a single locus variation (summed tandem repeat
differences .10) after MLVA analysis. Two of the Irish
isolates in this study were isolated in 2008, when an outbreak
of ribotype 078 was reported (Burns et al., 2010a), and
therefore may be more likely to be clonal. In addition, all
three Irish isolates reported by Bakker et al. (2010) were
found to be tetracycline susceptible and, as shown here,
isolates with similar antimicrobial-susceptibility profiles are
more likely to be related by rep-PCR.
The diversity identified in ribotype 078 rep-PCR subtypes
could be explained by reports that ribotype 078 is more
Fig. 2. rep-PCR dendrogram including electropherograms of all isolates of ribotype 027 from 2006 (marked with asterisks) and
2009. rep-PCR subtypes with .90% similarity are identified (by the dashed boxes). Major subtypes (1 and 2) were assigned
where three or more isolates clustered together; minor subtypes (3 and 4) were assigned where pairs of isolates were similar.
Isolates are identified by hospital source, toxinotype and origin of infection (HCAI, health-care-associated infection; HCAI NH,
health-care-associated infection from a nursing home; Unk, unknown origin). Antimicrobial-susceptibility profiles were assigned
on the basis of resistance (shaded) to clindamycin (CM), erythromycin (EM), moxifloxacin (MX) and levofloxacin (LE).
Epidemiology of C. difficile ribotypes 027 and 078
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commonly associated with community onset of disease and
that this ribotype is more commonly found outside
the health-care environment (Notermans et al., 2008).
Transmission from environment-to-person may mean that
ribotype 078 isolates have not yet fully adapted to the
human niche for clonal expansion, although reports of CDI
due to ribotype 078 are becoming more frequent (Burns et
al., 2010a; Goorhuis et al., 2008a; Rupnik et al., 2008). It
could therefore be suggested that ribotype 027 infections
are more likely than those of ribotype 078 to be transmitted
by person-to-person routes, ensuring a clonal genetic
identity within the population of the former.
We postulate that the degree of rep-PCR type variability
within PCR ribotypes means that it is not yet possible to
directly apply the results of rep-PCR to ribotyping in every
case without conducting the two typing methods simulta-
neously. However, by increasing the numbers of isolates
analysed by both methods and uploading the profiles into a
central online DiversiLab library, future users of this
technique may be able to reliably define subtypes and
ribotypes by comparing their profiles to a comprehensive
library.
Correlation with antimicrobial-susceptibility
profiles
Analysis of the antimicrobial-susceptibility profiles for
ribotype 027 identified two different profiles. Isolates of a
similar susceptibility profile generally clustered together and
isolates of subtype 1 were significantly more likely to be
clindamycin sensitive (P,0.05) than those in subtype 2,
suggesting a strong correlation between subtypes and
clindamycin resistance. Of the four isolates from 2009 that
were resistant to clindamycin, two were cultured from
patients for whom the origin of infection was a nursing home.
Fig. 3. rep-PCR dendrogram including electropherograms of all isolates of ribotype 078 from 2006 (marked with asterisks) and
2009. rep-PCR subtypes with .90% similarity are identified (by the dashed boxes). Major (1 and 2) and minor subtypes (3, 4
and 5) were assigned as detailed in Fig. 2. Isolates are identified by hospital source, toxinotype and origin of infection (HCAI,
health-care-associated infection; HCAI NH, health-care-associated infection from a nursing home; C, community-acquired;
Unk, unknown origin). Antimicrobial-susceptibility profiles were assigned on the basis of resistance (shaded) to clindamycin
(CM), erythromycin (EM), moxifloxacin (MX) and levofloxacin (LE).
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Ribotype 078 isolates were categorized into eight very
diverse susceptibility profiles that correlated with subtyp-
ing in only two instances (subtypes 3 and 4). This diversity
within ribotype 078 subtypes suggests that isolates may
have acquired novel mechanisms of resistance, possibly due
to selection pressures that are encountered in a variety of
environmental reservoirs and not normally seen in human
reservoirs. Of particular note is the presence of clindamycin
resistance in the absence of erythromycin resistance in two
isolates of ribotype 078. This unusual phenotype has been
reported in Streptococcus pneumoniae and in Enterococcus
faecium associated with the linB gene, although it has yet to
be confirmed inC. difficile (Bozdogan et al., 1999;Montagnani
et al., 2007).
Resistance to clindamycin is most commonly associated
with the insertion of one or more genes such as ermB
located on transposons into the C. difficile genome, which
may have altered the rep-PCR fingerprint profiles of these
isolates. Correlation between molecular typing and clin-
damycin resistance has also been seen in ribotype 027
isolates by MLVA (Drudy et al., 2008) and ribotype 001 by
randomly amplified polymorphic DNA (Fawley et al.,
2003) with distinct resistant and susceptible clones
identified.
Comparison within a hospital
Comparisons between ribotype 027 subtypes within
hospital F confirmed the genetic and antimicrobial-
susceptibility profile similarity (Fig. 4a). Isolates clustered
into two subtypes on the basis of a 90% similarity
threshold, with two outlying isolates, one obtained in 2009
and another from 2006, unrelated to the clusters.
Comparisons between ribotype 078 subtypes within
hospital A confirmed the genetic and antimicrobial-
susceptibility profile diversity (Fig. 4b). The closest
Fig. 4. rep-PCR dendrograms of isolates of ribotype 027 from hospital F (a) and isolates of ribotype 078 from hospital A (b).
rep-PCR subtypes with .90% similarity are identified (by the dashed boxes). Major (1) and minor (4) subtypes were assigned
as detailed in Fig. 2. Isolates are identified by hospital source, toxinotype and origin of infection (HCAI, health-care-associated
infection; HCAI NH, health-care-associated infection from a nursing home; Unk, unknown origin). Antimicrobial-susceptibility
profiles were assigned on the basis of resistance (shaded) to clindamycin (CM), erythromycin (EM), moxifloxacin (MX) and
levofloxacin (LE).
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similarity between isolates was 85%. Two susceptibility
profiles were unique to this hospital, characterized by the
presence of both fluoroquinolone and MLSB resistance,
which is unusual in ribotype 078 isolates.
Comparison between ribotyped isolates from
2006 and 2009
Members of the major subtype of ribotype 027 isolates
analysed from 2006 clustered closely together (subtype 2;
Fig. 2), but were unrelated to the predominant subtype
circulating in 2009 (all 027 isolates from 2006 marked with
an asterisk in Fig. 2). Clindamycin resistance was
significantly more common in ribotype 027 isolates from
2006 than in the prevalent subtype in 2009 (P,0.01),
which were predominantly clindamycin susceptible. A shift
in the predominant ribotype 027 subtype has occurred,
characterized by the loss of clindamycin resistance, and the
new susceptible subtype has spread nationwide. Restriction
and pre-authorization for use of clindamycin during
nosocomial outbreaks of CDI has proven to be an effective
measure to promptly limit outbreaks (Climo et al., 1998;
Pear et al., 1994). Implementation of these policies was
unlikely, however, to have selected for the recent
dominance of the clindamycin-sensitive subtype as clin-
damycin usage in Ireland is relatively low [0.46 defined
daily dose per 100 bed days in 2006 and 0.49 defined daily
dose per 100 bed days in 2008 (HPSC–HSE, 2008)]. The
most likely cause therefore is the introduction of a
clindamycin-resistant strain in 2006 that was initially
successful amongst other Irish strains, but was gradually
replaced by a sensitive strain without the selection pressure
of antibiotics. The prescribing policy in nursing homes,
however, may be less restrictive, favouring the emergence
of clindamycin-resistant isolates from recent infections that
originated in these facilities.
Comparisons between ribotype 078 isolates from 2006
(marked with an asterisk in Fig. 3) and 2009 identified close
relationships between isolates (subtype 1; Fig. 3) suggesting
the persistence of certain subtypes with very little genetic
change. Many new subtypes have, however, been introduced
since 2006 that are radically diverse both genetically and in
their antimicrobial-susceptibility profiles.
Conclusion
We investigated the heterogeneity of clinical C. difficile
isolates of ribotypes 027 and 078 by a semi-automated
DiversiLab rep-PCR method to investigate the epidemi-
ology of these clinically important strains within health-
care facilities. Ribotype 027 isolates were significantly more
likely to be closely related to each other than ribotype 078
isolates. Ribotype 078 isolates also exhibited a wider range
of antimicrobial-susceptibility profiles, suggesting that
ribotype 078 infections may have originated from a variety
of non-health-care and environmental sources. A shift in
the predominant circulating subtype of ribotype 027 was
identified between 2006 and 2009 from a clindamycin-
resistant subtype to clindamycin-susceptible subtype similar
to PFGE type NAP-1 that is now widespread within Ireland.
Preventing the emergence of novel antimicrobial-resistant
subtypes, mainly from community and environmental
sources, should also be a priority and implemented by
employing strict antimicrobial-usage policies in general
practice and food production methods.
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